Drug-drug Interaction Study of XZP-3621 Tablet

Clinical trial NCT05586568 · UNKNOWN

Trial details

NCT number: NCT05586568
Sponsor: Xuanzhu Biopharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2022-11-15
Primary completion: 2023-04-05
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.